1
|
Jia WP, Bao YQ, Miao H, Tu P, Liu Y, Yang T, Wang WB, Shi BY, Liu M, Hua WJ, Hou NN, Zhang Q, Hu L, Pang SG, Liu JD, Wang GX. [Comparison of efficacy and safety of insulin aspart injection Rishulin and NovoRapid for treatment of diabetes: a multicenter, randomized, open-labeled, controlled trial]. Zhonghua Nei Ke Za Zhi 2021; 60:1148-1156. [PMID: 34856687 DOI: 10.3760/cma.j.cn112138-20210127-00075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Objective: To compare the efficacy and safety of Tonghua Dongbao's insulin aspart injection (Rishulin) and NovoRapid (Novo Nordisk) in the treatment of diabetes. Methods: A 26-week, randomized, open-label, parallel-group, positive control drug and non-inferiority trial was conducted in 23 centers in China. A total of 563 diabetes with poor blood glucose control treated with insulin for at least 3 months before were included. The subjects were randomized(stratified block random method) into those receiving Rishulin or NovoRapid at a ratio of 3∶1. Both groups were combined with basal insulin (Lantus). The primary endpoint was the change in glycosylated hemoglobin (HbA1c) from baseline to the end of 24 weeks of treatment. Results: For full analysis set, after 24 weeks of treatment, HbA1c level of Ruishulin group decreased from (8.66±1.28)% to (7.77±1.09)% (P<0.001), and that of NovoRapid group decreased from (8.47±1.28) % to (7.65±0.97) % (P<0.001). Treatment difference in HbA1c (NovoRapid group-Ruishulin group) was -0.061% (95%CI -0.320-0.199). HbA1c<7.0% target reacing rates were 24.26% and 21.21% (P=0.456), and HbA1c<6.5% target reacing rates were 9.65% and 6.82% (P=0.310) in Ruishulin group and NovoRapid group, repectively. The standard 2 hours postprandial blood glucose (2hPG) in Ruishulin group decreased from (16.23±5.22) mmol/L to (12.65±4.57) mmol/L (P<0.001), and 2hPG in NovoRapid group decreased from (16.13±5.37) mmol/L to (11.91)±4.21) mmol/L (P<0.001). The fingertips blood glucose at 7-point of both groups exhibited varying degrees of reduction compared with those at baseline, repectively. Positive ratios of specific antibodies were 31.68% in Ruishulin group and 36.36% in NovoRapid group (P=0.320). Ratios of negative to positive were 7.43% and 10.61% (P=0.360), and ratios of positive to negative were 10.40% and 7.58% (P=0.360) in Ruishulin group and NovoRapid group, respectively. The incidence of hypoglycemia was 60.05% and 55.40% (P=0.371), and the incidence of adverse events was 76.60% and 77.70% (P=0.818) in Ruishulin group and NovoRapid group, respectively. Conclusions: Rishulin is not inferior to NovoRapid, and has shown good efficacy and safety. It can be an ideal choice for clinicians in patients with poor blood glucose control with insulin.
Collapse
Affiliation(s)
- W P Jia
- Department of Endocrinology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China
| | - Y Q Bao
- Department of Endocrinology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China
| | - H Miao
- Department of Endocrinology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China
| | - P Tu
- Department of Endocrinology, Nanchang Third Hospital, Nanchang 330009, China
| | - Y Liu
- Department of Endocrinology, Second Hospital of Jilin University, Changchun 130041, China
| | - T Yang
- Department of Endocrinology, Jiangsu Province People's Hospital, Nanjing 210029, China
| | - W B Wang
- Department of Endocrinology, Shougang Hospital of Peking University, Beijing 100144, China
| | - B Y Shi
- Department of Endocrinology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - M Liu
- Department of Endocrinology, General Hospital of Tianjin Medical University,Tianjin 300020,China
| | - W J Hua
- Department of Endocrinology, Wuxi Third People's Hospital, Wuxi 214043, China
| | - N N Hou
- Department of Endocrinology, Affiliated Hospital of Weifang Medical College, Weifang, Shandong 261033, China
| | - Q Zhang
- Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
| | - L Hu
- Department of Endocrinology, Nanchang First Hospital, Nanchang 330008, China
| | - S G Pang
- Department of Endocrinology, Ji'nan Central Hospital, Ji'nan 250013, China
| | - J D Liu
- Department of Endocrinology, Jiangxi Province People's Hospital, Nanchang 330006, China
| | - G X Wang
- Department of Endocrinology, First Hospital of Jilin University, Changchun 130021, China
| |
Collapse
|
2
|
Gal-On A, Meiri E, Huet H, Hua WJ, Raccah B, Gaba V. Particle bombardment drastically increases the infectivity of cloned DNA of zucchini yellow mosaic potyvirus. J Gen Virol 1995; 76 ( Pt 12):3223-7. [PMID: 8847534 DOI: 10.1099/0022-1317-76-12-3223] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
An infectious full-length cDNA clone of the RNA genome of the potyvirus zucchini yellow mosaic virus (ZYMV) was constructed under the control of the cauliflower mosaic virus 35S promoter. All squash, cucumber, melon and watermelon plants inoculated with the cloned cDNA of ZYMV by particle bombardment become infected. Bombardment technology is 10(6)-fold more effective than mechanical inoculation. Due to the great increase in efficiency, ineffective constructs now became infective (i.e. cDNA under the control of the 35S promoter without the NOS terminator; with an addition of 127 nucleotides at the 5' end of the viral cDNA; uncapped transcripts), and the infectivity of capped-transcripts was maximized. Inoculation by particle bombardment produced visual symptoms rapidly (3-4 days), allowing the detection of viral coat protein and virions after 2 and 3 days in systemically infected leaves and inoculated cotyledons respectively.
Collapse
Affiliation(s)
- A Gal-On
- Department of Virology, Agricultural Research Organization, Volcani Center, Bet Dagan, Israel
| | | | | | | | | | | |
Collapse
|